News

Biotech Vertex Pharmaceuticals stock tumbled on news of disappointing drug data. CEO Reshma Kewalramani paid nearly $4 ...
It's the second time this year the stock has slumped significantly in one day, and it might represent another attractive ...
And one of the best ways to cash in on that is to invest in stocks that can exceed the market's performance. Two that look ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Additionally, there was a pronounced slowdown in customers’ own business growth. This is also problematic because this means ...
Oracle and Google partner to offer AI models in Oracle's apps, running on Google servers, accessible through Vertex AI.
Sanofi's Tzield is now the first and only disease-modifying therapy to be approved for type 1 diabetes (T1D) in the UK.
Dr. Narinder Singh Kapany, Reshma Kewalramani, Jay Chaudhry, Maya Ajmera, and Vivek Chaand Sehgal are Indian-origin people ...
Oracle and Google Cloud (NASDAQ:GOOG) are stepping up their partnership and this one's about giving Oracle customers a big ...
In the future, Oracle said that it will collaborate with Google Cloud to make Gemini models via Vertex AI available as an ...
EVERSANA launches an 80% AI-powered pharma marketing agency built on Google Cloud to cut costs and speed brand campaigns.
By Padmanabhan Ananthan (Reuters) -In the latest setback for Pfizer's sickle cell anemia treatments, experimental drug ...